-
Forward Look
What’s NextA magnet-guided robot could help doctors look for signs of cancer deeper in the passages of the lungs.
by Darcy Lewis
-
Forward Look
Be Clear About Treatment GoalsPeople with late-stage cancer must ask what they want from treatment.
by Tyler Santora
-
Forward Look
Women, Men and Treatment Side EffectsStudy shows women have a higher risk of side effects from immunotherapy, adding to evidence that men and women react differently to treatment.
by Delia O'Hara
-
From the Editor-in-Chief
Cancer and AgingCancer cells exploit an aging "infrastructure" to threaten life in those 60 and older.
by William G. Nelson, MD, PhD
-
Cultural Competence in the CommunityResearchers describe their efforts to understand and improve cancer screening and treatment among underserved populations.
by Kevin McLaughlin
-
Working Toward the End of Cancer Health DisparitiesAACR conference explores the science of cancer disparities and what needs to be done to improve cancer outcomes for all people.
by Eric Fitzsimmons
-
Taking Stock of CAR T-Cell TherapyFive years after the FDA approved the first CAR T-cell therapy, use of the treatment has expanded to many patients with blood cancer.
by Kendall K. Morgan
-
Diet and Cancer: Getting the Research Onto Your PlateNew studies each year purport to show associations between certain foods and cancer. Experts say to focus on the big picture.
by Anne Danahy
-
How Common Are Treatment Breakthroughs?A new study adds nuance to the ‘golden age’ of cancer drug approvals.
by Jon Kelvey
-
New Guidelines Recommend Exercise for Most Cancer PatientsPeople in treatment for early-stage cancer should try to get exercise, according to new recommendations.
by Sandra Gordon
New research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff
-
AACR Grant Propels Progress in Immunotherapy ResearchA grant from the American Association for Cancer Research (AACR) helped Marco Ruella, MD, develop a new approach to immunotherapy.
-
Self-screening for Cancer: Home Sweet HomeNew cervical cancer self-screening options and a portable blood test device could lead to changes in at-home cancer screening.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
